234 related articles for article (PubMed ID: 24261152)
1. Traditional vs. nontraditional pharmacy.
Allen LV
Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152
[No Abstract] [Full Text] [Related]
2. End-preparation assessments and tests for compounded sterile preparations.
McElhiney LF
Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
[TBL] [Abstract][Full Text] [Related]
3. United States Parmacopeia Chapter <797> timeline: 1989 to 2013.
Newton DW
Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142
[TBL] [Abstract][Full Text] [Related]
4. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
Akers MJ
Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
[TBL] [Abstract][Full Text] [Related]
5. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
6. Does your pharmacy have a compounding isolator?
LaBella CJ
Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
[No Abstract] [Full Text] [Related]
7. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
Noorian S; Vahedi N
Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
[TBL] [Abstract][Full Text] [Related]
8. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
[TBL] [Abstract][Full Text] [Related]
9. FDA inspections find unsafe practices in compounding pharmacies.
McCarthy M
BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
[No Abstract] [Full Text] [Related]
10. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
[TBL] [Abstract][Full Text] [Related]
11. IACP's continuing support of compounding pharmacists: letter to the FDA concerning 503B outsourcing facilities.
Miller DG
Int J Pharm Compd; 2014; 18(2):117-8. PubMed ID: 24881114
[No Abstract] [Full Text] [Related]
12. The "Lists": What Do They Mean?
Voliva J
Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
[No Abstract] [Full Text] [Related]
13. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
14. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
15. Introduction to Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
[TBL] [Abstract][Full Text] [Related]
16. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
17. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
[No Abstract] [Full Text] [Related]
18. Types of pharmacy/pharmacists.
Williams LA
Int J Pharm Compd; 2013; 17(4):294-301. PubMed ID: 24261144
[TBL] [Abstract][Full Text] [Related]
19. Establishing powder-handling workflow practices and standard operating procedures: compounding pharmacy and safety.
Prince B; Lundevall J
Int J Pharm Compd; 2014; 18(3):222-6. PubMed ID: 25306770
[TBL] [Abstract][Full Text] [Related]
20. Compounding our problems--again.
Trissel LA
Am J Health Syst Pharm; 2003 Mar; 60(5):432. PubMed ID: 12635448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
